Proxima Raises $80 Million for AI Drug Discovery From DCVC, Nvidia

Proxima, a biotech startup using artificial intelligence to design drugs that control protein interactions, raised $80 million in seed funding, which will help it collect better data and eventually develop potential drug candidates.

The financing round was led by DCVC, with additional investors including Nvidia Corp., Roivant Sciences Ltd., and Braidwell LP.